Viewing nowCombinationDuo Forjizing 10/160 mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.

MFDS item code 201308469 · Approved 2013.07.30 · Insurance code 648203660
Improvement of blood pressure control in essential hypertension through the combination of amlodipine and valsartan
Essential hypertension is often treated with a combination approach when blood pressure is not sufficiently controlled by either amlodipine or valsartan alone. This allows for a more effective reduction in blood pressure and decreases the risk of cardiovascular diseases. This medication works by dilating blood vessels to regulate blood pressure and reducing the burden on the heart. It is designed for safe use in patients with chronic hypertension. Therefore, the combination therapy of amlodipine and valsartan is used for the improvement of essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is advisable to take it at the same time every day (e.g., morning). It is recommended to adjust the dosage with individual components (amlodipine or valsartan) before administration. If blood pressure is not adequately controlled, the following dosages may be administered: - 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy.
Safety and efficacy have not been established in pediatric patients under 18 years of age, and use of this medication is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with a known allergic reaction to this medication, pregnant or breastfeeding women, patients with severe kidney or liver impairment, or patients with certain heart diseases. Patients with sodium or fluid depletion may experience hypotension, so their condition should be corrected before taking the medication, and blood pressure and physical condition should be closely monitored during treatment. Patients with high potassium levels or those taking other medications that can increase potassium levels should frequently monitor their potassium levels. Patients with renal vascular issues or those who have received a kidney transplant should closely monitor kidney function while using this medication. If symptoms of angioedema, such as swelling of the face or neck, occur while taking this medication, it should be discontinued immediately and healthcare providers should be consulted. Patients with heart failure or post-myocardial infarction may experience changes in kidney function while taking this medication, thus regular check-ups are required. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. This medication may interact with other antihypertensives, potassium supplements, diuretics, certain pain relievers, and antibiotics, so it's important to inform your healthcare provider of any other medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid using it. The safety and effectiveness of this medication have not been adequately established in children under 18 years of age, so its use is not recommended in this population. In cases of overdose, severe hypotension or tachycardia, along with other cardiovascular abnormalities, may occur, so strict adherence to the dosage is necessary, and immediate medical attention should be sought for any abnormal symptoms.
Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash accompanied by high fever, blisters, peeling skin, pain in oral/ocular mucosa, severe skin adverse effects, difficulty or shortness of breath, asthma attacks, respiratory distress with cough and fever, jaundice (yellowing of the skin or eyes), profound malaise, liver abnormalities (jaundice), sudden and
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature.
Bright yellow oval film-coated tablet
30 tablets (10 tablets/PTP packaging x 3), 100 tablets (10 tablets/PTP packaging x 10), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.